440.87
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché ISRG Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$449.69
Aprire:
$449.24
Volume 24 ore:
1.69M
Relative Volume:
0.79
Capitalizzazione di mercato:
$157.97B
Reddito:
$9.15B
Utile/perdita netta:
$2.63B
Rapporto P/E:
61.52
EPS:
7.1661
Flusso di cassa netto:
$1.99B
1 W Prestazione:
-1.47%
1M Prestazione:
-5.61%
6M Prestazione:
-4.95%
1 anno Prestazione:
-6.49%
Intuitive Surgical Inc Stock (ISRG) Company Profile
Nome
Intuitive Surgical Inc
Settore
Industria
Telefono
(408) 523-2100
Indirizzo
1020 KIFER ROAD, SUNNYVALE
Confronta ISRG con altri titoli
Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
---|---|---|---|---|---|---|
![]()
ISRG
Intuitive Surgical Inc
|
440.68 | 161.20B | 9.15B | 2.63B | 1.99B | 7.1661 |
![]()
BDX
Becton Dickinson Co
|
192.59 | 55.03B | 21.39B | 1.61B | 2.55B | 5.5609 |
![]()
RMD
Resmed Inc
|
283.38 | 41.06B | 5.15B | 1.40B | 1.65B | 9.5082 |
![]()
ALC
Alcon Inc
|
75.35 | 37.98B | 10.03B | 1.07B | 1.39B | 2.1549 |
![]()
WST
West Pharmaceutical Services Inc
|
265.96 | 19.28B | 2.96B | 487.70M | 344.00M | 6.68 |
Intuitive Surgical Inc Stock (ISRG) Upgrades & Downgrades
Data | Azione | Analista | Modifica della valutazione |
---|---|---|---|
2025-07-23 | Downgrade | Erste Group | Buy → Hold |
2025-06-09 | Downgrade | Deutsche Bank | Hold → Sell |
2025-06-05 | Aggiornamento | Erste Group | Hold → Buy |
2024-12-02 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
2024-08-02 | Aggiornamento | Redburn Atlantic | Neutral → Buy |
2024-07-10 | Reiterato | Citigroup | Buy |
2024-05-30 | Iniziato | Goldman | Buy |
2023-11-17 | Iniziato | HSBC Securities | Buy |
2023-07-19 | Iniziato | Robert W. Baird | Outperform |
2023-04-19 | Reiterato | BTIG Research | Buy |
2023-04-19 | Reiterato | BofA Securities | Buy |
2023-04-19 | Reiterato | Citigroup | Buy |
2023-04-19 | Reiterato | Evercore ISI | In-line |
2023-04-19 | Reiterato | JP Morgan | Overweight |
2023-04-19 | Reiterato | Morgan Stanley | Equal-Weight |
2023-04-19 | Reiterato | RBC Capital Mkts | Outperform |
2023-04-19 | Reiterato | Raymond James | Outperform |
2023-04-19 | Reiterato | Stifel | Buy |
2023-04-19 | Reiterato | Truist | Buy |
2023-04-19 | Reiterato | Wells Fargo | Overweight |
2023-03-29 | Iniziato | UBS | Neutral |
2023-03-23 | Iniziato | William Blair | Outperform |
2022-10-18 | Iniziato | Barclays | Overweight |
2022-10-13 | Iniziato | Mizuho | Neutral |
2022-10-12 | Iniziato | Jefferies | Hold |
2022-04-13 | Iniziato | Truist | Buy |
2022-04-06 | Iniziato | Wolfe Research | Peer Perform |
2022-03-25 | Iniziato | RBC Capital Mkts | Outperform |
2022-03-02 | Ripresa | BofA Securities | Buy |
2022-02-02 | Aggiornamento | UBS | Neutral → Buy |
2022-01-31 | Aggiornamento | Piper Sandler | Neutral → Overweight |
2022-01-25 | Downgrade | Redburn | Buy → Neutral |
2022-01-21 | Reiterato | BTIG Research | Buy |
2022-01-21 | Aggiornamento | Citigroup | Neutral → Buy |
2022-01-21 | Reiterato | Deutsche Bank | Hold |
2022-01-21 | Reiterato | Evercore ISI | In-line |
2022-01-21 | Reiterato | Morgan Stanley | Equal-Weight |
2022-01-21 | Reiterato | Piper Sandler | Neutral |
2022-01-21 | Reiterato | Raymond James | Outperform |
2022-01-21 | Reiterato | Robert W. Baird | Outperform |
2022-01-21 | Reiterato | Stifel | Buy |
2022-01-21 | Reiterato | UBS | Neutral |
2022-01-21 | Reiterato | Wells Fargo | Overweight |
2022-01-10 | Aggiornamento | BTIG Research | Neutral → Buy |
2021-10-01 | Downgrade | Citigroup | Buy → Neutral |
2021-07-21 | Reiterato | BofA Securities | Neutral |
2021-07-21 | Reiterato | Citigroup | Buy |
2021-07-21 | Reiterato | JP Morgan | Overweight |
2021-07-21 | Reiterato | Morgan Stanley | Equal-Weight |
2021-07-21 | Reiterato | Piper Sandler | Neutral |
2021-07-21 | Reiterato | SVB Leerink | Mkt Perform |
2021-07-21 | Reiterato | Stifel | Buy |
2021-07-21 | Reiterato | UBS | Neutral |
2021-07-21 | Reiterato | Wells Fargo | Overweight |
2021-07-14 | Reiterato | Goldman | Buy |
2021-06-01 | Aggiornamento | Evercore ISI | Underperform → In-line |
2021-04-21 | Aggiornamento | Oppenheimer | Underperform → Perform |
2021-04-21 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
2021-04-01 | Iniziato | Citigroup | Buy |
2020-12-15 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
2020-09-28 | Iniziato | Argus | Buy |
2020-09-11 | Iniziato | Wolfe Research | Outperform |
2020-09-08 | Downgrade | BofA Securities | Buy → Neutral |
2020-09-02 | Iniziato | Robert W. Baird | Neutral |
2020-07-20 | Reiterato | Bernstein | Outperform |
2020-04-28 | Downgrade | Piper Sandler | Overweight → Neutral |
2020-04-17 | Downgrade | CFRA | Hold → Sell |
2020-04-17 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
2020-04-09 | Downgrade | Evercore ISI | In-line → Underperform |
2020-04-01 | Downgrade | Oppenheimer | Perform → Underperform |
2020-01-27 | Downgrade | Deutsche Bank | Buy → Hold |
2019-12-12 | Reiterato | Wells Fargo | Outperform |
2019-11-21 | Iniziato | Oppenheimer | Perform |
2019-07-19 | Reiterato | Canaccord Genuity | Buy |
2019-04-22 | Reiterato | Canaccord Genuity | Buy |
2019-04-02 | Iniziato | Deutsche Bank | Buy |
2018-10-31 | Reiterato | Piper Jaffray | Overweight |
2018-10-19 | Aggiornamento | Canaccord Genuity | Hold → Buy |
Mostra tutto
Intuitive Surgical Inc Borsa (ISRG) Ultime notizie
Evercore ISI Adjusts Intuitive Surgical Price Target to $450 From $535, Maintains In Line Rating - MarketScreener
1 Reason I'm Watching Intuitive Surgical Stock in 2026 - The Globe and Mail
1 Reason I'm Watching Intuitive Surgical Stock in 2026 - The Motley Fool
Surgical Robotic System Market Poised for Significant Growth - openPR.com
Should You Buy Shares of Intuitive Surgical In October? - sharewise.com
Will Intuitive Surgical Inc. (IUI1) stock keep high P E multiplesJuly 2025 WrapUp & Real-Time Market Sentiment Reports - newser.com
Is Intuitive Surgical Inc. stock affected by interest rate hikesWeekly Profit Analysis & Weekly Market Pulse Alerts - newser.com
How Intuitive Surgical Inc. stock performs in high volatility marketsQuarterly Profit Report & Free Weekly Watchlist of Top Performers - newser.com
The top surgical robotics stories of 2025 so far - MassDevice
How higher bond yields impact Intuitive Surgical Inc. (IUI1) stockWeekly Profit Recap & Capital Efficiency Focused Ideas - newser.com
Evaluating Intuitive Surgical Inc. with trendline analysis2025 Stock Rankings & AI Forecasted Stock Moves - newser.com
Is Intuitive Surgical Inc. showing signs of accumulationWeekly Stock Report & Weekly Setup with High ROI Potential - newser.com
Is Intuitive Surgical Inc. still worth holding after the dipTrade Analysis Summary & Stepwise Trade Signal Guides - newser.com
Visual trend scoring systems applied to Intuitive Surgical Inc.Quarterly Profit Review & Community Consensus Trade Signals - newser.com
Intuitive Surgical Inc Stock Analysis and ForecastHead and Shoulders Patterns & Free Professional Investment Consultations - earlytimes.in
How AI-Powered da Vinci 5 Expansion and Global Growth Could Influence Intuitive Surgical (ISRG) Investors - simplywall.st
How to build a custom watchlist for Intuitive Surgical Inc.July 2025 Earnings & Reliable Momentum Entry Alerts - newser.com
Multi asset correlation models including Intuitive Surgical Inc.Quarterly Profit Report & Expert Approved Momentum Ideas - newser.com
Intuitive Surgical, Inc. (NASDAQ:ISRG) Receives Consensus Recommendation of “Moderate Buy” from Analysts - Defense World
PATENT—Fed. Cir.: $10 million jury damages award cut to $1 despite proven infringement of surgical stapler patent - VitalLaw.com
Intuitive Surgical, Inc. (ISRG) Surpasses Market Returns: Some Facts Worth Knowing - sharewise.com
Reasons to Retain Intuitive Surgical Stock in Your Portfolio Now - MSN
How Does Intuitive Surgical Stack Up After Recent FDA Robot Surgery Guidance in 2025? - simplywall.st
Intuitive Surgical (ISRG): Assessing Valuation as New Telesurgery Advances and Global Regulatory Wins Drive Growth - simplywall.st
Morgan Stanley Remains Bullish on Intuitive Surgical (ISRG) - Insider Monkey
Intuitive Surgical Inc. (ISRG) Upgrades da Vinci 5 Making it 10,000 Times Powerful for Surgeries - MSN
Will Intuitive Surgical Inc. (IUI1) stock outperform benchmarksJuly 2025 Institutional & Low Risk Entry Point Tips - newser.com
How Intuitive Surgical Inc. (IUI1) stock trades in high volatilityMarket Volume Summary & AI Enhanced Trading Alerts - newser.com
Fed. Circ. Affirms Cutting $10M Med Device IP Verdict To $1 - Law360
Brokers Suggest Investing in Intuitive Surgical (ISRG): Read This Before Placing a Bet - sharewise.com
This Medical Device Giant Could Be Your Best Inflation Hedge - AOL.com
Congressional Trading Report: Sen. Markwayne Mullin Bought Over $81K In Intuitive Surgical Stock - Benzinga
Intuitive Surgical Stock (ISRG) Opinions on Recent Performance and Innovation - Quiver Quantitative
Meet the 3%-Yielding Dividend Stock That Could Soar in 2026 - AOL.com
Intuitive Surgical’s (ISRG) “Buy” Rating Reaffirmed at BTIG Research - Defense World
Intuitive Surgical (NASDAQ:ISRG) Price Target Lowered to $567.00 at The Goldman Sachs Group - Defense World
Best Healthcare Stocks To Keep An Eye On – September 30th - Defense World
What You Need To Know Ahead of Intuitive Surgical's Earnings Release - MSN
Intuitive Surgical, Inc. (ISRG) Unveils AI-Powered da Vinci 5 Upgrades - MSN
SS Innovations International, Inc. (SSII)’s SSi Mantra System Sees 130% Installation Growth, Pioneers Cardiac Telesurgery - MSN
ISRG Expands SP Indications: A Game Changer in Colorectal Surgery? - The Globe and Mail
Intuitive Surgical Inc (ISRG) Stock Price, Trades & News - GuruFocus
Is Intuitive Surgical the Hidden Winner in Healthcare’s Weakness? - MarketBeat
The top Intuitive Surgical stories of 2025 so far - MassDevice
BTIG Reiterates Intuitive Surgical (ISRG) Buy Recommendation - Nasdaq
Goldman Sachs Adjusts Price Target on Intuitive Surgical to $567 From $621, Maintains Buy Rating - MarketScreener
Intuitive Surgical Inc Azioni (ISRG) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):